|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Otani K, Li X, Arakawa T, Chan FK and Yu
J: Epigenetic-mediated tumor suppressor genes as diagnostic or
prognostic biomarkers in gastric cancer. Expert Rev Mol Diagn.
13:445–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu S, Huang S, Ding J, Zhao Y, Liang L,
Liu T, Zhan R and He X: Multiple microRNAs modulate p21Cip1/Waf1
expression by directly targeting its 3′untranslated region.
Oncogene. 29:2302–2308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carleton M, Cleary MA and Linsley PS:
MicroRNAs and cell cycle regulation. Cell Cycle. 6:2127–2132. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boehm M and Slack FJ: MicroRNA control of
lifespan and metabolism. Cell Cycle. 5:837–840. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baltimore D, Boldin MP, O'Connell RM, Rao
DS and Taganov KD: MicroRNAs: New regulators of immune cell
development and function. Nat Immunol. 9:839–845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsu KW, Wang AM, Ping YH, Huang KH, Huang
TT, Lee HC, Lo SS, Chi CW and Yeh TS: Downregulation of tumor
suppressor MBP-1 by microRNA-363 in gastric carcinogenesis.
Carcinogenesis. 35:208–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song JH and Meltzer SJ: MicroRNAs in
pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
Gastroenterology. 143:35–47.e2. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sarver AL, Li L and Subramanian S:
MicroRNA miR-183 functions as an oncogene by targeting the
transcription factor EGR1 and promoting tumor cell migration.
Cancer Res. 70:9570–9580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li C, Deng L, Zhi Q, Meng Q, Qian A, Sang
H, Li X and Xia J: MicroRNA-183 functions as an oncogene by
regulating PDCD4 in gastric cancer. Anticancer Agents Med Chem.
16:447–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu L, Li Y, Yan D, He J and Liu D:
MicroRNA-183 inhibits gastric cancer proliferation and invasion via
directly targeting Bmi-1. Oncol Lett. 8:2345–2351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanaka K, Shimura T, Kitajima T, Kondo S,
Ide S, Okugawa Y, Saigusa S, Toiyama Y, Inoue Y, Araki T, et al:
Tropomyosin-related receptor kinase B at the invasive front and
tumour cell dedifferentiation in gastric cancer. Br J Cancer.
110:2923–2934. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kamiya A, Inokuchi M, Otsuki S, Sugita H,
Kato K, Uetake H, Sugihara K, Takagi Y and Kojima K: Prognostic
value of tropomyosin-related kinases A, B, and C in gastric cancer.
Clin Transl Oncol. 18:599–607. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pierce ML, Weston MD, Fritzsch B, Gabel
HW, Ruvkun G and Soukup GA: MicroRNA-183 family conservation and
ciliated neurosensory organ expression. Evol Dev. 10:106–113. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bandrés E, Cubedo E, Agirre X, Malumbres
R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M and
García-Foncillas J: Identification by real-time PCR of 13 mature
microRNAs differentially expressed in colorectal cancer and
non-tumoral tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Motoyama K, Inoue H, Takatsuno Y, Tanaka
F, Mimori K, Uetake H, Sugihara K and Mori M: Over- and
under-expressed microRNAs in human colorectal cancer. Int J Oncol.
34:1069–1075. 2009.PubMed/NCBI
|
|
23
|
Agirre X, Jiménez-Velasco A, San
José-Enériz E, Garate L, Bandrés E, Cordeu L, Aparicio O, Saez B,
Navarro G, Vilas-Zornoza A, et al: Down-regulation of hsa-miR-10a
in chronic myeloid leukemia CD34+ cells increases
USF2-mediated cell growth. Mol Cancer Res. 6:1830–1840. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Macedo T, Silva-Oliveira RJ, Silva VAO,
Vidal DO, Evangelista AF and Marques MMC: Overexpression of mir-183
and mir-494 promotes proliferation and migration in human breast
cancer cell lines. Oncol Lett. 14:1054–1060. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang G, Mao W and Zheng S: MicroRNA-183
regulates Ezrin expression in lung cancer cells. FEBS Lett.
582:3663–3668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gunning PW, Hardeman EC, Lappalainen P and
Mulvihill DP: Tropomyosin-master regulator of actin filament
function in the cytoskeleton. J Cell Sci. 128:2965–2974. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zare M, Jazii FR, Soheili ZS and
Moghanibashi MM: Downregulation of tropomyosin-1 in squamous cell
carcinoma of esophagus, the role of Ras signaling and methylation.
Mol Carcinog. 51:796–806. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Redwood C and Robinson P:
Alpha-tropomyosin mutations in inherited cardiomyopathies. J Muscle
Res Cell Motil. 34:285–294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Perry SV: Vertebrate tropomyosin:
Distribution, properties and function. J Muscle Res Cell Motil.
22:5–49. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pawlak G and Helfman DM: Cytoskeletal
changes in cell transformation and tumorigenesis. Curr Opin Genet
Dev. 11:41–47. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Helfman DM, Flynn P, Khan P and Saeed A:
Tropomyosin as a regulator of cancer cell transformation. Adv Exp
Med Biol. 644:124–131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bharadwaj S and Prasad GL: Tropomyosin-1,
a novel suppressor of cellular transformation is downregulated by
promoter methylation in cancer cells. Cancer Lett. 183:205–213.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Raval GN, Bharadwaj S, Levine EA,
Willingham MC, Geary RL, Kute T and Prasad GL: Loss of expression
of tropomyosin-1, a novel class II tumor suppressor that induces
anoikis, in primary breast tumors. Oncogene. 22:6194–6203. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pawlak G, McGarvey TW, Nguyen TB,
Tomaszewski JE, Puthiyaveettil R, Malkowicz SB and Helfman DM:
Alterations in tropomyosin isoform expression in human transitional
cell carcinoma of the urinary bladder. Int J Cancer. 110:368–373.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dube S, Yalamanchili S, Lachant J, Abbott
L, Benz P, Mitschow C, Dube DK and Poiesz BJ: Expression of
tropomyosin 1 gene isoforms in human breast cancer cell lines. Int
J Breast Cancer. 2015:8594272015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bakin AV, Safina A, Rinehart C, Daroqui C,
Darbary H and Helfman DM: A critical role of tropomyosins in
TGF-beta regulation of the actin cytoskeleton and cell motility in
epithelial cells. Mol Biol Cell. 15:4682–4694. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang J, Guan J, Lu Z, Jin J, Cai Y, Wang C
and Wang F: Clinical and tumor significance of tropomyosin-1
expression levels in renal cell carcinoma. Oncol Rep. 33:1326–1334.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cao LL, Xie JW, Lin Y, Zheng CH, Li P,
Wang JB, Lin JX, Lu J, Chen QY and Huang CM: miR-183 inhibits
invasion of gastric cancer by targeting Ezrin. Int J Clin Exp
Pathol. 7:5582–5594. 2014.PubMed/NCBI
|
